Employer record no. 19525
AbbVie Biotherapeutics
US DOL LCA disclosure data, FY2020 to FY2023
Total LCA filings
15
Certified
14
Denied
0
FY2023 filings
1
Filings by fiscal year
Peer rank
#1,767 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 4 | 4 | 0 | $121,625 | $101,073 |
| FY2021 | 9 | 8 | 0 | $113,444 | $107,305 |
| FY2022 | 1 | 1 | 0 | $120,000 | $100,880 |
| FY2023 | 1 | 1 | 0 | $170,000 | $110,240 |
What they file for
- scientist i, analytical development & quality control, cmc b$105,0003
- associate director, cell therapy cmc$165,0001
- associate director, cmc program strategy$170,0001
- associate scientist ii, protein analytical chemistry$85,0001
- manager statistical programming$153,0001
- scientist ii, bioprocess development$100,0001
- scientist ii, car-t cellular therapy, discovery$110,0001
- scientist ii, cell therapy$96,0001
Where
- redwood city, ca9
- south san francisco, ca6
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for AbbVie Biotherapeutics and any other employer they watch.
Certification rate 93.3%How these numbers are computed